Neuroprotective peptide drug delivery and development: Potential new therapeutics

Illana Gozes*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Alzheimer's disease and related neurodegenerative disorders are prevalent among the elderly and might be considered as the plague of the 21st century. It is thus imperative to find cures for these conditions. The use of nerve growth factor proteins as neuroprotective therapeutics is limited by their hindered mobility through the blood-brain barrier. Peptides provide an attractive alternative. However, do peptide derivatives retain the activity of the entire protein? Are they stable? Would peptides cross the blood-brain barrier and what are the potential side effects? Examples are put forth to strengthen our opinion that peptides are important candidates for future drug development.

Original languageEnglish
Pages (from-to)700-705
Number of pages6
JournalTrends in Neurosciences
Issue number12
StatePublished - 1 Dec 2001


Dive into the research topics of 'Neuroprotective peptide drug delivery and development: Potential new therapeutics'. Together they form a unique fingerprint.

Cite this